Verana Health Launches Neurology Qdata
Neurology model will help power real-world evidence generation into the rare-disease patient journey.
Verana Health today announced the launch of its Neurology Qdata, available through Verana Health's real-world evidence service offerings.
Neurology Qdata comprises disease-specific datasets to help power neuroscience research and shape therapeutic strategies. Qdata SMA, the first neurology module to launch, is a real-world de-identified dataset reflective of spinal muscular atrophy (SMA) patients found across healthcare settings.
Following the release of Qdata SMA, Verana Health expects to release additional Neurology Qdata modules for neurological diseases including Parkinson's Disease, multiple sclerosis, Neuromyelitis Optica Spectrum Disorder (NMOSD), and others.
Read more about this new model
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025